scholarly article | Q13442814 |
P356 | DOI | 10.1002/PD.1970120312 |
P698 | PubMed publication ID | 1375379 |
P2093 | author name string | J. Arends | |
B. Nørgaard-Pedersen | |||
S. Smidt-Jensen | |||
S. O. Larsen | |||
C. K. Høgdall | |||
E. V. Høgdall | |||
P2860 | cites work | Reactivity of a monoclonal antibody with human ovarian carcinoma | Q24600879 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | serum marker | Q129938692 |
P304 | page(s) | 223-227 | |
P577 | publication date | 1992-03-01 | |
P1433 | published in | Prenatal Diagnosis | Q15760059 |
P1476 | title | CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters | |
P478 | volume | 12 |
Q73937660 | Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome |
Q50939462 | Amniotic fluid and maternal serum levels of CA125 in pregnancies affected by Down syndrome: a re-evaluation of the role of CA125 in Down syndrome screening. |
Q36308492 | First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. |
Q33768998 | First trimester screening for aneuploidy: serum biochemical markers |
Q24187589 | First trimester serum tests for Down's syndrome screening |
Q36308489 | First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening |
Q34333074 | First-trimester biochemical screening for Down syndrome |
Q22252964 | Second trimester serum tests for Down's Syndrome screening |
Q47339171 | Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme |
Q72087901 | The use of free β‐hCG in antenatal screening for Down's syndrome |
Q24186912 | Urine tests for Down's syndrome screening |
Search more.